Skip Navigation


NDT Advance Access originally published online on March 14, 2008
Nephrology Dialysis Transplantation 2008 23(8):2552-2557; doi:10.1093/ndt/gfn083
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/8/2552    most recent
gfn083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Litwin, M.
Right arrow Articles by Schaefer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litwin, M.
Right arrow Articles by Schaefer, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease

Mieczyslaw Litwin1, Elke Wühl2, Claudia Jourdan3, Anna Niemirska1, Jens P. Schenk3,2, Katarzyna Jobs1, Ryszard Grenda1, Zbigniew T. Wawer1, Pawel Rajszys4, Otto Mehls2 and Franz Schaefer2

1 Department of Nephrology, The Children's Memorial Health Institute, Warsaw, Poland 2 Division of Paediatric Nephrology 3 Department of Paediatric Radiology, Hospital for Paediatric and Adolescent Medicine, University of Heidelberg, Germany 4 Department of Radiology, The Children's Memorial Health Institute, Warsaw, Poland

Correspondence and offprint requests to: Mieczyslaw Litwin, Department of Nephrology, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04–730 Warsaw, Poland. Email: m.litwin{at}czd.pl



   Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
This observational study was designed to verify the hypothesis that the treatment modality significantly affects the evolution of CKD-associated arteriopathy.

Patients. Paediatric patients (mean age 13.8 ± 4.2 years) with chronic kidney disease (CKD) stages 3–5, including 24 patients with mean GFR 54 ± 21 ml/min/1.73 m2 (CKD group) and 32 patients in end-stage renal disease, of whom 19 received a renal allograft (D-Rtx) and 13 remained on dialysis (D-D).

Methods. Sonography of the common carotid artery was performed at baseline and after 12 months. Intima-media thickness (IMT) and the cross-sectional areas of the vessel wall (WCSA) and lumen (LCSA) were measured and normalized to age (SDS).

Results. At baseline IMT-SDS and WCSA-SDS were increased above normal, and were significantly higher in D than in CKD patients (P < 0.001). IMT-SDS increased over time in CKD and D-D patients (1.4 ± 1.7 to 2.1 ± 1.2, P = 0.05). In contrast, IMT-SDS (2.8 ± 0.6 to 2.0 ± 0.6, P < 0.005) decreased in those D-Rtx patients who had elevated values prior to transplantation. The total number of patients with elevated cIMT-SDS changed from 7 to 13 in the 24 CKD, from 8 to 11 in the 13 D-D and from 11 to 12 in the 19 D-Rtx patients. While IMT-SDS was independently correlated with blood pressure and serum phosphate in the CKD and D patients, only total dialysis vintage (r = 0.50; P < 0.05) and the IMT-SDS attained at the time of grafting (r = 0.46, P < 0.05) correlated with IMT-SDS 1 year post-Rtx.

Conclusion. While vascular lesions rapidly progress in CKD and D patients, abolition of the uraemic state by Rtx leads to stabilization or partial regression of CKD-associated arteriopathy. Cumulative dialysis duration and the degree of arterial damage prevalent at the time of grafting are the main determinants of persistent arteriopathy 1 year after Rtx.

Keywords: atherosclerosis; chronic kidney disease; hypertension; paediatrics; risk factors

Cardiovascular complications are one of the leading causes of long-term morbidity and mortality in patients with chronic kidney disease (CKD) [1–5]. Progressive renal dysfunction is associated with multiple biochemical and haemodynamic alterations that profoundly affect the cardiovascular system. CKD patients typically develop a calcifying arteriopathy affecting both the intima and the tunica media of large arteries [6–8]. Population-based studies have suggested that cardiovascular risk is increased significantly even with mild impairment of kidney function, and becomes excessive as renal failure progresses. Patients undergoing renal transplantation (Rtx) have a significantly better long-term survival than subjects remaining on dialysis. So far, a few uncontrolled studies have suggested that good graft function is associated with improved blood pressure control and decreases in left ventricular mass and carotid intima-media thickness (IMT) [9,10].

The paediatric age group is uniquely suited for the study of cardiovascular abnormalities in CKD since confounding comorbidities such as diabetes mellitus and age-related atherosclerosis are largely absent. Registry analyses have suggested that children with CKD are at high risk for cardiac and arterial disease, and that cardiovascular disease is a leading cause of death in this age group. In a recent cross-sectional study in children we noted an elevation of IMT as early as in stage 2 CKD, an inverse correlation of IMT with GFR, most marked carotid artery thickening in children on maintenance dialysis, and significantly lower IMT in renal allograft recipients [11]. Based on these observations we hypothesized that successful Rtx, by improving some of the metabolic alterations associated with uraemia, may permit regression of arteriopathic changes. In order to test this hypothesis we performed a longitudinal observational study in children with CKD and in dialyzed patients who either continued this treatment or received a renal allograft.



   Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Patients
Fifty-six children with CKD stages 2–5 in Warsaw and Heidelberg were included in the trial. Of these, 24 patients (14 boys) aged 12.8 ± 4 years with mean initial GFR 55 ± 25 ml/min/1.73 m2 were treated conservatively throughout the period of observation (CKD group). Of 31 patients who were on maintenance dialysis (haemodialysis in 15, CPD in 16) at the start of follow-up, 18 patients (7 boys) received a kidney allograft and one patient with CKD had preemptive kidney transplantation (D-Rtx group). Thirteen patients (11 boys) remained on dialysis (D-D group). Three patients in the D-D group were >20 years of age. The duration of CKD was defined as the time from the first detection of GFR <80 ml/min/1.73 m2 calculated from Schwartz formula (Table 1). Exclusion criteria from the study included any clinically overt inflammatory disease at the time of screening, clinically significant over- or dehydration, acute rejection or rapidly progressive chronic allograft nephropathy at the time of second examination, presence of venous dialysis catheters near the site of ultrasonographic evaluation, and any clinically significant severe comorbidity such as diabetes, cardiac, metabolic or inflammatory systemic disease. Renal allograft recipients received standard triple immunosuppression using cyclosporine or tacrolimus (n = 2), mycophenolate mofetil and prednisone.


View this table:
[in this window]
[in a new window]

 
Table 1 Clinical characteristics of the three patient cohorts

 
The study was approved by the local Ethical Committees in Warsaw and Heidelberg. A written informed consent was obtained from the parents and consent or verbal assent from the patients as appropriate.

Study protocol
The study design was prospective and observational. All measurements and biochemical analyses were performed at baseline (time point 0) and then after a mean time of 12.0 ± 4.4 months. In patients on haemodialysis, sonography was performed after the dialysis session on the mid-week day. In the D-Rtx group a baseline measurement was performed on the day of renal transplantation. Blood samples were collected during routine visits on the day of sonographic assessment. Parathormone (PTH) concentrations were measured with the ELISA method (Diagnostic System Laboratories, Webster, TX, USA) (normal range: 12–62 pg/ml).

Sonographic measurements
The methodology of sonographic measurements was described previously [11]. All measurements were performed by the same observer in each centre (ML in Warsaw, CJ in Heidelberg). High-resolution ultrasound [Acuson Sequoia (Acuson Inc., Mountain View, CA, USA) or Philips ATL 5000 HDI (Royal Philips Electronics, The Netherlands)] using a linear array transducer adjusted to 12.5–13 MHz was performed with subjects in supine position with slightly overextended neck, following at least 10 min rest. Blood pressure was measured before starting the examination and again on the ipsilateral arm during M-mode examination of each common carotid artery.

B-mode measurements were performed on both common carotid arteries. The carotid arteries were assessed 1–2 cm proximal to the bifurcation over a range of 1 cm of the far wall. IMT was defined as the distance between the leading edges of the lumen–intima interface and the media–adventitia interface of the far wall. The scans with the far-wall image were frozen at diastole.

For the M-mode measurement, a B-mode image was used to direct the M-mode ultrasound beam perpendicular to the walls of the CCA segment with the same adjustments and transducer positions. Wall motion was recorded for five consecutive heartbeats. The freezing point was chosen so that all the structures of interest, the near-wall intima–lumen interfaces and the far-wall lumen–intima interfaces were clearly visible. The lumen diameters were measured for systolic and diastolic pulse phases. All B- and M-mode images were saved in digital form and analysed off-line by one investigator in each centre who was fully unaware of the health status of each subject (PR in Warsaw and CJ in Heidelberg). Only images accepted as of good quality were taken to further analysis.

For every variable at least five to six measurements were taken from each arterial scan. The results were averaged for each side and presented as the mean value of both arteries.

The reproducibility of sonographic measurements was calculated from repeated measurements of 10 subjects by the two observers and expressed by the repeatability coefficient: RC = {Sigma}Di2/n, where Di is the difference between each pair of measurements and n is the number of examined subjects [12]. The intra-observer RC for IMT was 4.5 µm, for systolic diameter 276 µm and for diastolic diameter 277 µm. The inter-observer RC was 2 µm for IMT, 370 µm for systolic and 119 µm for diastolic diameter. This level of reproducibility compares favourably with previous studies [12–14].

Calculations
Lumen cross-sectional area (LCSA) and wall cross-sectional area (WCSA) were calculated from values of diastolic and systolic diameters of artery and blood pressure according to previously published equations [12–14].

The following parameters were calculated:

Mean systolic diameter (sD) = (LsD + RsD)/2, where LsD is left and RsD right CCA systolic diameter.

Mean diastolic diameter (dD) = (RdD + LdD)/2, where LdD is left and RdD right CCA diastolic diameter.

Mean lumen cross-sectional area of the artery (LCSA) = {pi}(dD)2/4

Mean wall cross-sectional area (WCSA) = {pi}(dD/2 + IMT)2{pi}(dD/2)2

Statistics
Since carotid artery dimensions and blood pressure change with age during childhood and adolescence [15,16], the sonographic and blood pressure measurements were normalized to standard deviation scores (SDS) for within- and between-group comparisons and correlation analysis. SDS were calculated using the LMS method of Cole and Green to account for the non-Gaussian distribution of the variables in the general population [17]. Recently published reference values from 250 healthy Polish and German school children and adolescents were used for comparison [15]. For the three patients who were <20 years of age (20, 21 and 23, respectively), IMT was normalized to values observed in 20-year-old healthy adolescents.

Results are expressed as mean and standard deviation (SD) when parameters showed Gaussian distribution. In the case of non-normal distribution, results are presented as median and interquartile range (i.e. PTH concentrations).

Homogeneity of variance was checked with the Levene test. Between-group comparisons of parameters with Gaussian distribution were performed by ANOVA followed by Student's Newman Keuls testing. Parameters with non-normal distribution were compared using the Mann–Whitney U-test. Student's paired t-testing was used to perform intragroup longitudinal comparisons. Spearman correlation coefficients were used throughout to express associations between variables.

Stepwise multiple regression analysis was performed to assess predictors of standardized IMT. P < 0.05 was regarded as significant.

Statement of responsibility
The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.



   Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Patient characteristics
The baseline and follow-up patient characteristics are given in Tables 1 and 2.


View this table:
[in this window]
[in a new window]

 
Table 2 Comparison of blood pressure and biochemical characteristics in the three cohorts at baseline (upper rows) and follow-up examination (lower rows)

 
Carotid artery measures
At baseline, dialyzed patients exhibited significantly greater measures than CKD patients for IMT-SDS (2.2 ± 1.4 versus 1 ± 1.5) (Table 2, Figure 1), WCSA-SDS (2.6 ± 1.6 versus 0.7 ± 1.5) and LCSA-SDS (1.3 ± 1.3 versus –0.3 ± 1) (all P = 0.001). Overall, IMT-SDS was above normal in 7 of 24 CKD patients, 8 of 13 D-D patients and 13 of 19 D-Rtx patients. In the patients who remained in CKD or on dialysis during follow-up, an increase of IMT-SDS (1.4 ± 1.7 to 2.1 ± 1.2, P = 0.05) and WCSA-SDS (1.1 ± 1.6 to 1.7 ± 1.3, P = 0.09) was observed over time. cIMT decreased in 4 CKD, 5 D-D patients and 11 D-Rtx patients. At follow-up, 13 of 24 CKD patients, 11 of 13 D-D patients and 12 of 19 D-Rtx patients had cIMT values still above normal. The clinical characteristics of these patients (blood pressure, time in CKD, dialysis vintage, biochemical variables) did not differ from those of the other patients in the respective groups.


Figure 1
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1 Evolution of IMT-SDS between first and second observation in the three cohorts. Shaded area denotes normal range, with SDS –1.64, 0 and 1.64 corresponding to 5th, 50th and 95th percentile.

 
In contrast, in the D-Tx patients IMT-SDS decreased significantly (P = 0.019) (Table 3). In the patients with elevated IMT-SDS (>1.64) at baseline, both IMT-SDS (2.8 ± 0.6 to 2.0 ± 0.6, P < 0.005) and WCSA-SDS (3.5 ± 1.3 to 2.5 ± 1.3, P = 0.05) decreased significantly.


View this table:
[in this window]
[in a new window]

 
Table 3 Comparison of sonographic carotid artery measures in the three cohorts at baseline (upper rows) and follow-up examination (lower rows).

 
Univariate and multivariate predictors of IMT
The results of the univariate correlation analysis are summarized in Table 4. At baseline, IMT-SDS was inversely correlated in the total cohort with GFR and positively with systolic and diastolic BP-SDS (Figure 2), serum phosphate, LDL cholesterol and uric acid levels. In the patients who remained with renal failure (CKD or D) during the observation period, persistent correlations with GFR, serum phosphate and blood pressure were noted and in D-D patients also with dialysis vintage. In the 19 D-Tx patients, only dialysis vintage was significantly associated with IMT-SDS both at first and at second examination after transplantation. The total time spent on dialysis and the IMT-SDS attained prior to transplantation (r = 0.46, P < 0.01) were the only significant correlates of IMT-SDS at follow-up.


View this table:
[in this window]
[in a new window]

 
Table 4 Univariate correlation analysis of IMT-SDS versus clinical, blood pressure and biochemical characteristics

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2 Standardized diastolic BP is associated with standardised IMT in paediatric patients.

 
Stepwise multiple linear regression analysis disclosed that the mean IMT-SDS in the CKD/D-D patients was independently predicted by the mean systolic BP-SDS (ß: 0.26, partial R2: 0.13, P < 0.05) and, with borderline significance, mean serum phosphate levels (ß: 0.84, partial R2: 0.06, P = 0.13). In the D-Tx group, no variables other than the IMT-SDS attained at the end of the dialysis period were identified as additional independent predictors of IMT-SDS.



   Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
This study provides evidence that successful renal transplantation may induce partial regression of the large-vessel arteriopathy associated with uraemia in children and adolescents within 1 year of follow-up. In contrast, continued renal failure is associated with measurable progression of vascular lesions.

Sonographic IMT measurement is an accepted quantitative measure of atherosclerosis and vascular damage [18]. In adult dialysis patients the sonographic IMT status is an excellent prognostic marker that can be used for cardiovascular risk stratification [19]. Increased IMT has been reported in young adults with childhood-onset end-stage renal disease [20] and, more recently, in children with different stages of CKD. In cross-sectional comparisons [11,21] carotid IMT was most markedly elevated in children on dialysis, but was increased also in renal allograft recipients and even in children with stage 2–4 CKD [11]. The baseline assessment of the children followed in this study confirms that while the vascular pathology including the cross-sectional areas of the carotid wall and lumen is most marked in children on dialysis, vascular alterations are present even at a mean glomerular filtration rate of 54 ml/min/ 1.73 m2.

The significant arteriopathy in children with CKD, a population much less exposed to confounding general cardiovascular risk factors such as diabetes, smoking and dyslipidaemia than adult patients, is intriguing and permits a sensitive assessment of the role of disease-specific metabolic and haemodynamic abnormalities in the pathophysiology of uraemic arteriopathy. Previous studies suggested that abnormalities of mineral metabolism, hypertension and inflammation may be causally involved in the pathogenesis of vascular lesions in childhood-onset CKD [11,19,21,22]. Our current analysis confirms a quantitative association of carotid IMT with blood pressure and serum phosphate. In addition, significant correlations with LDL cholesterol and uric acid were noted, compatible with a role of these metabolic parameters in the aetiology of uraemic arteriopathy [23]. Since blood pressure and the various biochemical alterations of uraemia are interrelated, a multiple linear regression analysis was performed that suggested independent roles of hypertension and hyperphosphataemia. It should be emphasized, however, that these factors explained only 20% of the variance of IMT; hence, additional as yet unidentified mechanisms are most likely to be involved.

An important novel aspect of this study relates to the dynamics of vascular lesions both during ongoing renal failure and after removal of the uraemic state by successful kidney transplantation. Within a period of on average 12 months IMT increased significantly, by ~0.7 SD, in patients who remained in CKD or on dialysis. Conversely, in dialysis patients with elevated IMT who received a renal allograft, IMT regressed by an average of 0.6 SD within 1 year of grafting. IMT decreased significantly mainly in those subjects who had abnormally elevated IMT at baseline, indicating a trend toward improvement of a pathological condition and arguing against non-specific effects of factors related to transplantation, such as changes in intravascular hydration or a general anti-inflammatory effect of the immunosuppressive medication.

The observed partial regression provides prospective confirmatory evidence to the impression from cross-sectional studies that, at least in some children and adolescents, arteriopathy is partially reversible by removal of the uraemic state. In contrast, in a single uncontrolled study performed in adult patients, significant regression of IMT did not occur before the third post-transplant year despite regression of left ventricular mass within 12 months [9]. Similarly, Zoungas et al. did not observe a significant change in carotid IMT within 12 months after Rtx, although the elastic properties of the large arteries improved markedly [24]. The apparently more rapid reversal of the morphological changes observed here may be related to the shorter exposure of paediatric patients to conventional and uraemia-specific vascular risk factors, or indicate a better efficiency of repair mechanisms in children. Also, the D-Tx patients attained an almost normal GFR and were exposed relatively shortly to potentially vasculopathic effects of immunosuppressive drugs, hypertension and infections that may interfere with vascular recovery after transplantation. Finally, we cannot entirely exclude that the apparent decrease of IMT in the D-RTx group was partially biased by a random regression to the mean phenomenon in this longitudinal study. However, such an effect was not seen in the other experimental groups.

It is difficult to assess the removal of which uraemic abnormality was most relevant to the regression of arteriopathy. Renal transplantation was associated with a slight decrease in blood pressure levels, at a substantially reduced need for antihypertensive medication. Also, hyperphosphataemia and the serum calcium–phosphorus ion product were normalized. However, such associations do not prove causality. Isbel et al. recently found that aggressive and targeted treatment of cardiovascular risk factors in adults with CKD stage 4–5, despite decreasing blood pressure and LDL-cholesterol, did not lead to a decrease of carotid IMT or cardiovascular events [25]. Moreover, none of the haemodynamic and metabolic parameters at the time of transplantation was predictive of IMT-SDS 1 year later. Only the IMT level attained at the time of grafting and the total duration of dialysis correlated with the later IMT score, compatible with the notion that the vascular damage caused by end-stage renal failure is multifactorial, time-sensitive and only partly reversible.

The relatively small number of patients studied limits to some degree the conclusions that can be drawn from this work. Another potential limitation is the wide age range studied, which increased sample heterogeneity by inclusion of variable age specific vascular risk factors, such as treatment non-adherence and tobacco smoking in the adolescent population. On the other hand, these factors should not affect the main conclusions obtained by intraindividual longitudinal comparison.

In summary, this longitudinal assessment of IMT changes over time in paediatric CKD patients provides substantial evidence that progressive vascular lesions occur even in children with moderate renal disease, and are in part reversible after successful renal transplantation. Our findings permit the conclusion that extended periods of dialysis should be avoided, and kidney transplantation performed as soon as possible in paediatric CKD patients in order to minimize the exposure to vasculopathogenic factors and improve the long-term cardiovascular prognosis of this patient population.



   Acknowledgments
 
This study was supported by EU grant QLGI-CT-2002-00908, the Boehringer Ingelheim Stiftung and the Kuratorium für Dialyse und Nierentransplantation.

Conflict of interest statement. None declared.



   References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. United States Renal Data System. USRDS 1999 Annual Data Report, National Institutes of Heath, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, 1999. Available at www.usrds.org/chapters/ch06.pdf.
  2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kid Dis (1998) 32(Suppl_3):S112–S119.[Web of Science][Medline]
  3. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol (1998) 11:239–245.[Web of Science][Medline]
  4. Litwin M, Grenda R, Prokurat S, et al. Survival and causes of death in children on hemodialysis and continuous ambulatory peritoneal dialysis. Pediatr Nephrol (2001) 16:996–1001.[CrossRef][Web of Science][Medline]
  5. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children. Kidney Int (2002) 61:621–629.[CrossRef][Web of Science][Medline]
  6. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int (2002) 62:1402–1407.[CrossRef][Web of Science][Medline]
  7. Stam F, van Guldener C, Becker A, et al. Endothelial dysfunction contributes to renal function associated cardiovascular mortality in a population wit mild renal insufficiency: the Hoorn Study. J Am Soc Nephrol (2006) 17:537–545.[Abstract/Free Full Text]
  8. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Eng J Med (2004) 351:1285–1295.[Abstract/Free Full Text]
  9. De Lima JJG, Vieira MLC, Viviani LF, et al. Long-term impact of renal transplantation on carotid artery properties and on vascular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant (2002) 17:645–651.[Abstract/Free Full Text]
  10. Suwelack B, Gerhardt U, Witta J, et al. Effect of homocysteine on carotid intima-media thickness after renal transplantation. Clin Transplant (2000) 14:555–560.[CrossRef][Web of Science][Medline]
  11. Litwin M, Wuhl E, Jourdan C, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol (2005) 16:1494–1500.[Abstract/Free Full Text]
  12. Aggoun Y, Sidi D, Levy BI, et al. Mechanical properties of the common carotid artery in Williams syndrome. Heart (2000) 84:290–293.[Abstract/Free Full Text]
  13. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet (2001) 358:1400–1404.[CrossRef][Web of Science][Medline]
  14. Litwin M, Trelewicz J, Antoniewicz J, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol (2004) 20:767–774.
  15. Jourdan C, Wühl E, Litwin M, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens (2005) 23:1707–15.[Web of Science][Medline]
  16. Sass C, Herbeth B, Chapel O, et al. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens (1998) 16:1593–1602.[CrossRef][Web of Science][Medline]
  17. Cole TJ, Green PJ. Smoothing references centile curves: the LMS method and penalized likelihood. Stat Med (1992) 11:1305–1319.[Web of Science][Medline]
  18. Guidelines Committee: 2003 European Society of Hypertension–European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertension (2003) 21:1011–1053.[CrossRef][Web of Science][Medline]
  19. Benedetto FA, Mallamaci F, Tripepi G, et al. Prognostic value of ultrasonographic measurement of carotid intima-media thickness in dialysis patients. J Am Soc Nephrol (2001) 12:2458–2464.[Abstract/Free Full Text]
  20. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 106:100–105.[Abstract/Free Full Text]
  21. Mitsnefes MM, Kimball TR, Kartel J, et al. Cardiac and vascular adaptation in paediatric patients with chronic renal diseases: role of calcium-phosphorus metabolism. J Am Soc Nephrol (2005) 16:2799–2803.
  22. Mitsnefes MM, Kimball TR, Witt SA, et al. Abnormal carotid artery structure and function in children and adolescents after successful renal transplantation. Circulation (2004) 110:97–101.[Abstract/Free Full Text]
  23. Preston E, Ellis MR, Kulinskaya E, et al. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kid Dis (2005) 46:856–862.[CrossRef][Web of Science][Medline]
  24. Zoungas S, Kerr PG, Chadban S, et al. Arterial function after successful renal transplantation. Kidney Int (2004) 65:1882–1889.[CrossRef][Web of Science][Medline]
  25. Isbel NM, Haluska B, Johnson DW, et al. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J (2006) 151:745–753.[CrossRef][Web of Science][Medline]
Received for publication: 16. 4.07
Accepted in revised form: 29. 1.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. A. Bakkaloglu, A. Saygili, L. Sever, A. Noyan, S. Akman, M. Ekim, N. Aksu, B. Doganay, N. Yildiz, A. Duzova, et al.
Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3525 - 3532.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
R. Shroff
MONITORING CARDIOVASCULAR RISK FACTORS IN CHILDREN ON DIALYSIS
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S173 - S175.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/8/2552    most recent
gfn083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Litwin, M.
Right arrow Articles by Schaefer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litwin, M.
Right arrow Articles by Schaefer, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?